{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:59:13Z","timestamp":1794970753444,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["NHMRC APP1063092"],"award-info":[{"award-number":["NHMRC APP1063092"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victorian Cancer Agency (AU)Fellowship"},{"name":"Melbourne International Research Scholarship"},{"name":"Melbourne International Fee Remission Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13058-018-0967-1","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:04:23Z","timestamp":1525251863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape"],"prefix":"10.1186","volume":"20","author":[{"given":"Tanjina","family":"Kader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prue","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad A.","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie L.","family":"Gorringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"issue":"3","key":"967_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL. Risk Factors for Breast Cancer in Women with Proliferative Breast Disease. N Engl J Med. 1985;312(3):146\u201351.","journal-title":"N Engl J Med"},{"issue":"4","key":"967_CR2","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I","volume":"71","author":"WD Dupont","year":"1993","unstructured":"Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71(4):1258\u201365.","journal-title":"Cancer"},{"issue":"4","key":"967_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/cncr.29775","volume":"122","author":"LC Collins","year":"2016","unstructured":"Collins LC, Aroner SA, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Breast cancer risk by extent and type of atypical hyperplasia: an update from the Nurses\u2019 Health Studies. Cancer. 2016;122(4):515\u201320.","journal-title":"Cancer"},{"issue":"6","key":"967_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10552-010-9508-7","volume":"21","author":"GC Kabat","year":"2010","unstructured":"Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control. 2010;21(6):821\u20138.","journal-title":"Cancer Causes Control"},{"issue":"3","key":"967_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"LC Hartmann","year":"2005","unstructured":"Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353(3):229\u201337.","journal-title":"N Engl J Med"},{"issue":"11","key":"967_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","volume":"289","author":"CI Li","year":"2003","unstructured":"Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA. 2003;289(11):1421\u20134.","journal-title":"JAMA"},{"issue":"1","key":"967_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr1407164","volume":"372","author":"LC Hartmann","year":"2015","unstructured":"Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast\u2014risk assessment and management options. N Engl J Med. 2015;372(1):78\u201389.","journal-title":"N Engl J Med"},{"issue":"19","key":"967_CR8","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","volume":"25","author":"AC Degnim","year":"2007","unstructured":"Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007;25(19):2671\u20137.","journal-title":"J Clin Oncol"},{"issue":"2","key":"967_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","volume":"7","author":"LC Hartmann","year":"2014","unstructured":"Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, Tarabishy Y, Ghosh K, Visscher DW, Degnim AC. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res. 2014;7(2):211\u20137.","journal-title":"Cancer Prev Res"},{"key":"967_CR10","unstructured":"Walia S, Ma Y, Lu J, Lang JE, Press MF. Pathology and current management of borderline breast epithelial lesions. Am J Hematol\/Oncol\u00ae. 2017;14(8):24\u201331."},{"issue":"19","key":"967_CR11","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1002\/cncr.30153","volume":"122","author":"AC Degnim","year":"2016","unstructured":"Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, et al. Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women. Cancer. 2016;122(19):2971\u20138.","journal-title":"Cancer"},{"issue":"1","key":"967_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1200\/JCO.2003.02.137","volume":"21","author":"N Hoogerbrugge","year":"2003","unstructured":"Hoogerbrugge N, Bult P, LMd W-L, Beex LV, Kiemeney LA, Ligtenberg MJL, Massuger LF, Boetes C, Manders P, Brunner HG. High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. J Clin Oncol. 2003;21(1):41\u20135.","journal-title":"J Clin Oncol"},{"issue":"11","key":"967_CR13","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1158\/1055-9965.EPI-09-0745","volume":"18","author":"TS Menes","year":"2009","unstructured":"Menes TS, Kerlikowske K, Jaffer S, Seger D, Miglioretti DL. Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2822\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"967_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12885-017-3082-2","volume":"17","author":"RA Vierkant","year":"2017","unstructured":"Vierkant RA, Degnim AC, Radisky DC, Visscher DW, Heinzen EP, Frank RD, Winham SJ, Frost MH, Scott CG, Jensen MR, et al. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort. BMC Cancer. 2017;17(1):84.","journal-title":"BMC Cancer"},{"issue":"3","key":"967_CR15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/AOG.0b013e3181ee9fc7","volume":"116","author":"MD Pearlman","year":"2010","unstructured":"Pearlman MD, Griffin JL. Benign Breast Disease. Obstet Gynecol. 2010;116(3):747\u201358.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"967_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00428-007-0408-5","volume":"451","author":"I de Mascarel","year":"2007","unstructured":"de Mascarel I, MacGrogan G, Mathoulin-P\u00e9lissier S, Vincent-Salomon A, Soubeyran I, Picot V, Coindre J-M, Mauriac L. Epithelial atypia in biopsies performed for microcalcifications. Practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch. 2007;451(1):1\u201310.","journal-title":"Virchows Arch"},{"issue":"11","key":"967_CR17","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","volume":"55","author":"DL Page","year":"1985","unstructured":"Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698\u2013708.","journal-title":"Cancer"},{"issue":"10","key":"967_CR18","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1002\/1097-0142(19880515)61:10<2077::AID-CNCR2820611024>3.0.CO;2-M","volume":"61","author":"E Rubin","year":"1988","unstructured":"Rubin E, Visscher DW, Alexander RW, Urist MM, Maddox WA. Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer. 1988;61(10):2077\u201382.","journal-title":"Cancer"},{"issue":"11","key":"967_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","volume":"127","author":"H Welch","year":"1997","unstructured":"Welch H, Black WC. Using autopsy series to estimate the disease \u201creservoir\u201d for ductal carcinoma in situ of the breast: How much more breast cancer can we find? Ann Intern Med. 1997;127(11):1023\u20138.","journal-title":"Ann Intern Med"},{"key":"967_CR20","unstructured":"Page DL, Dupont WD, Rogers L, Rados M. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1959;35:2698\u20132708."},{"issue":"2","key":"967_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","volume":"57","author":"MA Lopez-Garcia","year":"2010","unstructured":"Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchio C, Reis-Filho JS. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology. 2010;57(2):171\u201392.","journal-title":"Histopathology"},{"key":"967_CR22","unstructured":"Biopsy Interpretation of the Breast. Wolters Kluwer\/Lippincott Williams & Wilkins; Biopsy Interpretation Series. Philadelphia: Epstein JI, series ed. 2009:4."},{"issue":"6","key":"967_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00428-006-0245-y","volume":"449","author":"M Ghofrani","year":"2006","unstructured":"Ghofrani M, Tapia B, Tavassoli FA. Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey. Virchows Arch. 2006;449(6):609\u201316.","journal-title":"Virchows Arch"},{"issue":"12","key":"967_CR24","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/00000478-199212000-00001","volume":"16","author":"SJ Schnitt","year":"1992","unstructured":"Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, Page DL. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol. 1992;16(12):1133\u201343.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"967_CR25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/modpathol.2011.66","volume":"24","author":"RK Jain","year":"2011","unstructured":"Jain RK, Mehta R, Dimitrov R, Larsson LG, Musto PM, Hodges KB, Ulbright TM, Hattab EM, Agaram N, Idrees MT. Atypical ductal hyperplasia: interobserver and intraobserver variability. Mod Pathol. 2011;24(7):917.","journal-title":"Mod Pathol"},{"issue":"2","key":"967_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2559.2005.02208.x","volume":"47","author":"A Douglas-Jones","year":"2005","unstructured":"Douglas-Jones A, Shah V, Morgan J, Dallimore N, Rashid M. Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5\/6, calponin and p63. Histopathology. 2005;47(2):202\u20138.","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"967_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1365-2184.36.s.1.7.x","volume":"36","author":"W Boecker","year":"2003","unstructured":"Boecker W, Buerger H. Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif. 2003;36(Suppl 1):73\u201384.","journal-title":"Cell Prolif"},{"issue":"3","key":"967_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00000478-199103000-00001","volume":"15","author":"J Rosai","year":"1991","unstructured":"Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol. 1991;15(3):209\u201321.","journal-title":"Am J Surg Pathol"},{"key":"967_CR29","doi-asserted-by":"crossref","unstructured":"Rageth CJ, O\u2019Flynn EA, Comstock C, Kurtz C, Kubik R, Madjar H, Lepori D, Kampmann G, Mundinger A, Baege A, et al. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat. 2016;159:203\u2013213.","DOI":"10.1007\/s10549-016-3935-4"},{"issue":"1","key":"967_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.path.2017.09.001","volume":"11","author":"BC Calhoun","year":"2018","unstructured":"Calhoun BC. Core needle biopsy of the breast: an evaluation of contemporary data. Surg Pathol Clin. 2018;11(1):1\u201316.","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"967_CR31","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/his.12852","volume":"68","author":"BC Calhoun","year":"2016","unstructured":"Calhoun BC, Collins LC. Recommendations for excision following core needle biopsy of the breast: a contemporary evaluation of the literature. Histopathology. 2016;68(1):138\u201351.","journal-title":"Histopathology"},{"issue":"3","key":"967_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-012-2318-8","volume":"136","author":"SB Coopey","year":"2012","unstructured":"Coopey SB, Mazzola E, Buckley JM, Sharko J, Belli AK, Kim EM, Polubriaginof F, Parmigiani G, Garber JE, Smith BL, et al. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 2012;136(3):627\u201333.","journal-title":"Breast Cancer Res Treat"},{"issue":"Supplement C","key":"967_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.breast.2017.01.002","volume":"32","author":"AR Skandarajah","year":"2017","unstructured":"Skandarajah AR, Thomas S, Shackleton K, Chin-Lenn L, Lindeman GJ, Mann GB. Patient and medical barriers preclude uptake of tamoxifen preventative therapy in women with a strong family history. Breast. 2017;32(Supplement C):93\u20137.","journal-title":"Breast"},{"issue":"2","key":"967_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10549-017-4253-1","volume":"164","author":"A Pe\u00f1a","year":"2017","unstructured":"Pe\u00f1a A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, Jakub JW, Boughey JC, Visscher DW, Degnim AC. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat. 2017;164(2):295\u2013304.","journal-title":"Breast Cancer Res Treat"},{"key":"967_CR35","doi-asserted-by":"crossref","unstructured":"Linsk A, Mehta TS, Dialani V, Brook A, Chadashvili T, Houlihan MJ, Sharma R. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model. Breast J. 2018;24:115\u2013119.","DOI":"10.1111\/tbj.12885"},{"issue":"4","key":"967_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrclinonc.2015.8","volume":"12","author":"M Morrow","year":"2015","unstructured":"Morrow M, Schnitt SJ, Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol. 2015;12(4):227.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"967_CR37","first-page":"13","volume":"65","author":"WB Hutchinson","year":"1980","unstructured":"Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B. Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst. 1980;65(1):13\u201320.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"967_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","volume":"267","author":"SJ London","year":"1992","unstructured":"London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267(7):941\u20134.","journal-title":"JAMA"},{"issue":"8","key":"967_CR39","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/0046-8177(89)90063-4","volume":"20","author":"WD Dupont","year":"1989","unstructured":"Dupont WD, Page DL. Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol. 1989;20(8):723\u20135.","journal-title":"Hum Pathol"},{"issue":"3","key":"967_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/cncr.29766","volume":"122","author":"DW Visscher","year":"2016","unstructured":"Visscher DW, Frost MH, Hartmann LC, Frank RD, Vierkant RA, McCullough AE, Winham SJ, Vachon CM, Ghosh K, Brandt KR, et al. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer. 2016;122(3):378\u201385.","journal-title":"Cancer"},{"key":"967_CR41","doi-asserted-by":"crossref","unstructured":"Danforth DN. Molecular profile of atypical hyperplasia of the breast. Breast Cancer Res Treat. 2018;167:9\u201329.","DOI":"10.1007\/s10549-017-4488-x"},{"issue":"7418","key":"967_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas N","year":"2012","unstructured":"Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature"},{"issue":"7","key":"967_CR43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/jcp.48.7.611","volume":"48","author":"S Lakhani","year":"1995","unstructured":"Lakhani S, Collins N, Stratton M, Sloane J. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol. 1995;48(7):611\u20135.","journal-title":"J Clin Pathol"},{"issue":"3","key":"967_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.1973","volume":"209","author":"PS Larson","year":"2006","unstructured":"Larson PS, de las Morenas A, Cerda SR, Bennett SR, Cupples LA, Rosenberg CL. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors. J Pathol. 2006;209(3):307\u201316.","journal-title":"J Pathol"},{"issue":"9","key":"967_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/jnci\/90.9.697","volume":"90","author":"P O'Connell","year":"1998","unstructured":"O'Connell P, Pekkel V, Allred DC, Fuqua SA, Osborne CK, Clark GM. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst. 1998;90(9):697\u2013703.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"967_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1148\/radiology.185.2.1329141","volume":"185","author":"P Stomper","year":"1992","unstructured":"Stomper P, Stewart C, Penetrante R, Nava M, Tsangaris T. Flow cytometric DNA analysis of excised breast lesions: use of fresh tissue needle aspirates obtained under guidance with mammography of the specimen. Radiology. 1992;185(2):415\u201322.","journal-title":"Radiology"},{"issue":"4","key":"967_CR47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.prp.2012.12.006","volume":"209","author":"Y Niu","year":"2013","unstructured":"Niu Y, Wang S, Liu T, Zhang T, Wei X, Wang Y, Jiang L. Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma. Pathol Res Pract. 2013;209(4):221\u20137.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"967_CR48","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0344-0338(99)80115-0","volume":"195","author":"A Ruiz","year":"1999","unstructured":"Ruiz A, Almenar S, Callaghan RC, Llombart-Bosch A. Benign, preinvasive and invasive ductal breast lesions. A comparative study with quantitative techniques: morphometry, image-and flow cytometry. Pathol Res Pract. 1999;195(11):741\u20136.","journal-title":"Pathol Res Pract"},{"issue":"12","key":"967_CR49","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/0046-8177(92)90056-9","volume":"23","author":"E Eriksson","year":"1992","unstructured":"Eriksson E, Schimmelpenning H, Silfversw\u00e4rd C, Auer G. Immunoreactivity with monoclonal antibody A-80 and nuclear DNA content in benign and malignant human breast disease. Hum Pathol. 1992;23(12):1366\u201372.","journal-title":"Hum Pathol"},{"issue":"12","key":"967_CR50","first-page":"1249","volume":"114","author":"J Crissman","year":"1990","unstructured":"Crissman J, Visscher DW, Kubus J. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Arch Pathol Lab Med. 1990;114(12):1249\u201353.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"967_CR51","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0046-8177(96)90104-5","volume":"27","author":"N Sneige","year":"1996","unstructured":"Sneige N, Sahin A, Dinh M, El-Naggar A. Interphase cytogenetics in mammographically detected breast lesions. Hum Pathol. 1996;27(4):330\u20135.","journal-title":"Hum Pathol"},{"issue":"5","key":"967_CR52","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/cncr.20558","volume":"102","author":"S Krishnamurthy","year":"2004","unstructured":"Krishnamurthy S, Zhao L, Hayes K, Glassman AB, Cristofanilli M, Singletary SE, Hunt KK, Kuerer HM, Sneige N. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens. Cancer Cytopathol. 2004;102(5):322\u20137.","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"967_CR53","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<315::AID-CNCR14>3.0.CO;2-4","volume":"77","author":"DW Visscher","year":"1996","unstructured":"Visscher DW, Wallis TL, Crissman JD. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer. 1996;77(2):315\u201320.","journal-title":"Cancer"},{"issue":"2","key":"967_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00109-008-0408-1","volume":"87","author":"Y Gao","year":"2009","unstructured":"Gao Y, Niu Y, Wang X, Wei L, Lu S. Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization. J Mol Med. 2009;87(2):145\u201352.","journal-title":"J Mol Med"},{"issue":"6","key":"967_CR55","first-page":"1469","volume":"19","author":"S Xu","year":"2008","unstructured":"Xu S, Wei B, Zhang H, Qing M, Bu H. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor. Oncol Rep. 2008;19(6):1469\u201376.","journal-title":"Oncol Rep"},{"issue":"1","key":"967_CR56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00019606-200003000-00003","volume":"9","author":"MM Aubele","year":"2000","unstructured":"Aubele MM, Cummings MC, Mattis AE, Zitzelsberger HF, Walch AK, Kremer M, H\u00f6fler H, Werner M. Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn Mol Pathol. 2000;9(1):14\u20139.","journal-title":"Diagn Mol Pathol"},{"issue":"7","key":"967_CR57","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1101\/gr.151670.112","volume":"23","author":"DE Newburger","year":"2013","unstructured":"Newburger DE, Kashef-Haghighi D, Weng Z, Salari R, Sweeney RT, Brunner AL, Zhu SX, Guo X, Varma S, Troxell ML. Genome evolution during progression to breast cancer. Genome Res. 2013;23(7):1097\u2013108.","journal-title":"Genome Res"},{"issue":"1","key":"967_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-015-0146-2","volume":"7","author":"Z Weng","year":"2015","unstructured":"Weng Z, Spies N, Zhu SX, Newburger DE, Kashef-Haghighi D, Batzoglou S, Sidow A, West RB. Cell-lineage heterogeneity and driver mutation recurrence in pre-invasive breast neoplasia. Genome Med. 2015;7(1):1.","journal-title":"Genome Med"},{"issue":"10","key":"967_CR59","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1158\/0008-5472.CAN-10-3667","volume":"71","author":"NJ Birkbak","year":"2011","unstructured":"Birkbak NJ, Eklund AC, Li Q, McClelland SE, Endesfelder D, Tan P, Tan IB, Richardson AL, Szallasi Z, Swanton C. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res. 2011;71(10):3447\u201352.","journal-title":"Cancer Res"},{"issue":"5","key":"967_CR60","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","volume":"6","author":"DP Slaughter","year":"1953","unstructured":"Slaughter DP, Southwick HW, Smejkal W. \u201cField cancerization\u201d in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer. 1953;6(5):963\u20138.","journal-title":"Cancer"},{"issue":"3","key":"967_CR61","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10549-017-4347-9","volume":"165","author":"R Arthur","year":"2017","unstructured":"Arthur R, Wang Y, Ye K, Glass AG, Ginsberg M, Loudig O, Rohan T. Association between lifestyle, menstrual\/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease. Breast Cancer Res Treat. 2017;165(3):623\u201331.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"967_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.2808","volume":"223","author":"A Bombonati","year":"2011","unstructured":"Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol. 2011;223(2):307\u201317.","journal-title":"J Pathol"},{"issue":"1","key":"967_CR63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/his.12796","volume":"68","author":"JMB Pang","year":"2016","unstructured":"Pang JMB, Gorringe KL, Fox SB. Ductal carcinoma in situ\u2013update on risk assessment and management. Histopathology. 2016;68(1):96\u2013109.","journal-title":"Histopathology"},{"issue":"11","key":"967_CR64","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1101\/gad.242511.114","volume":"28","author":"JE Visvader","year":"2014","unstructured":"Visvader JE, Stingl J. Mammary stem cells and the differentiation hierarchy: current status and perspectives. Genes Dev. 2014;28(11):1143\u201358.","journal-title":"Genes Dev"},{"issue":"2","key":"967_CR65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/modpathol.3880503","volume":"15","author":"R Xu","year":"2002","unstructured":"Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H. Amplification of Her-2\/neu gene in Her-2\/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material. Mod Pathol. 2002;15(2):116\u201324.","journal-title":"Mod Pathol"},{"issue":"9","key":"967_CR66","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/modpathol.2015.75","volume":"28","author":"KL Gorringe","year":"2015","unstructured":"Gorringe KL, Hunter SM, Pang JM, Opeskin K, Hill P, Rowley SM, Choong DY, Thompson ER, Dobrovic A, Fox SB, et al. Copy number analysis of ductal carcinoma in situ with and without recurrence. Mod Pathol. 2015;28(9):1174\u201384.","journal-title":"Mod Pathol"},{"issue":"6","key":"967_CR67","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1245\/s10434-010-0910-x","volume":"17","author":"RE Ellsworth","year":"2010","unstructured":"Ellsworth RE, Ellsworth DL, Weyandt JD, Fantacone-Campbell JL, Deyarmin B, Hooke JA, Shriver CD. Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression. Ann Surg Oncol. 2010;17(6):1688\u201394.","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"967_CR68","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1158\/1078-0432.CCR-07-4960","volume":"14","author":"VV Iakovlev","year":"2008","unstructured":"Iakovlev VV, Arneson NC, Wong V, Wang C, Leung S, Iakovleva G, Warren K, Pintilie M, Done SJ. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Clin Cancer Res. 2008;14(14):4446\u201354.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"967_CR69","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10549-011-1835-1","volume":"133","author":"CE Johnson","year":"2012","unstructured":"Johnson CE, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, Hill P, Mann GB, Campbell IG. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Breast Cancer Res Treat. 2012;133(3):889\u201398.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"967_CR70","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, Raine K, Jones D, Marshall J, Ramakrishna M. The life history of 21 breast cancers. Cell. 2012;149(5):994\u20131007.","journal-title":"Cell"},{"issue":"10","key":"967_CR71","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1101\/gr.187823.114","volume":"25","author":"LA Forsberg","year":"2015","unstructured":"Forsberg LA, Rasi C, Pekar G, Davies H, Piotrowski A, Absher D, Razzaghian HR, Ambicka A, Halaszka K, Przewoznik M, et al. Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer. Genome Res. 2015;25(10):1521\u201335.","journal-title":"Genome Res"},{"issue":"5","key":"967_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2014-15-5-r71","volume":"15","author":"AL Brunner","year":"2014","unstructured":"Brunner AL, Li J, Guo X, Sweeney RT, Varma S, Zhu SX, Li R, Tibshirani R, West RB. A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions. Genome Biol. 2014;15(5):1\u201316.","journal-title":"Genome Biol"},{"issue":"5","key":"967_CR73","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s004280050045","volume":"430","author":"ED Coene","year":"1997","unstructured":"Coene ED, Schelfhout V, Winkler RA, Schelfhout A-M, Roy NV, Grooteclaes M, Speleman F, Potter CD. Amplification units and translocation at chromosome 17q and c-erb B-2 overexpression in the pathogenesis of breast cancer. Virchows Arch. 1997;430(5):365\u201372.","journal-title":"Virchows Arch"},{"issue":"1","key":"967_CR74","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17305\/bjbms.2012.2533","volume":"12","author":"F Eren","year":"2012","unstructured":"Eren F, Calay Z, Durak H, Eren B, \u00c7omuno\u011flu N, Aydin \u00d6. C-Erb-b2 oncogene expression in intraductal proliferative lesions of the breast. Bosn J Basic Med Sci. 2012;12(1):41.","journal-title":"Bosn J Basic Med Sci"},{"issue":"10","key":"967_CR75","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.0931261100","volume":"100","author":"X-J Ma","year":"2003","unstructured":"Ma X-J, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A. 2003;100(10):5974\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"967_CR76","doi-asserted-by":"publisher","first-page":"e8768","DOI":"10.1371\/journal.pone.0008768","volume":"5","author":"AH Beck","year":"2010","unstructured":"Beck AH, Weng Z, Witten DM, Zhu S, Foley JW, Lacroute P, Smith CL, Tibshirani R, Van De Rijn M, Sidow A. 3\u2032-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One. 2010;5(1):e8768.","journal-title":"PLoS One"},{"issue":"5","key":"967_CR77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nm1243","volume":"11","author":"I Poola","year":"2005","unstructured":"Poola I, DeWitty RL, Marshalleck JJ, Bhatnagar R, Abraham J, Leffall LD. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis. Nat Med. 2005;11(5):481\u20133.","journal-title":"Nat Med"},{"issue":"1","key":"967_CR78","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrc.2017.102","volume":"18","author":"K Curtius","year":"2018","unstructured":"Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer. 2018;18(1):19.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"967_CR79","first-page":"1277","volume":"6","author":"M Amari","year":"1999","unstructured":"Amari M, Suzuki A, Moriya T, Yoshinaga K, Amano G, Sasano H, Ohuchi N, Satomi S, Horii A. LOH analyses of premalignant and malignant lesions of human breast: Frequent LOH in 8p, 16q, and 17q in atypical ductal hyperplasia. Oncol Rep. 1999;6(6):1277\u201380.","journal-title":"Oncol Rep"},{"issue":"8","key":"967_CR80","first-page":"2410","volume":"7","author":"G Gong","year":"2001","unstructured":"Gong G, DeVries S, Chew KL, Cha I, Ljung B-M, Waldman FM. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res. 2001;7(8):2410\u20134.","journal-title":"Clin Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-0967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-018-0967-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-0967-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T19:24:56Z","timestamp":1556738696000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-018-0967-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1186\/s13058-018-0967-1","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"2 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"39"}}